MedPath
TGA Approval

METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 36 mg modified release tablet bottle (370900)

370900

METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 36 mg modified release tablet bottle

Teva Pharma Australia Pty Ltd

October 13, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-02435-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-02263-1

Active Ingredients

methylphenidate hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 36 mg modified release tablet bottle (370900) - TGA 批准文号 | MedPath